Obesity-induced metabolic disturbance drives oxidative stress and complement activation in the retinal environment by Natoli, Riccardo et al.
In 2014, the World Health Organization reported that 
more than 1.9 billion adults (18 years or older) were classified 
as overweight, with 600 million reported as obese. This level 
of obesity equates to almost 10% of the global population. 
Obesity is a serious nutritional problem known to increase 
the risk and morbidity of many diseases, including diabetes, 
cardiovascular disease, and cancer (reviewed in [1]). Obesity 
has also been linked to several eye diseases, including age-
related macular degeneration (AMD) [2]. The retina under-
goes several pathophysiological changes with age, including 
photoreceptor and RPE cell death, activation and migration 
of microglia and macrophages into the outer retina, accu-
mulation of lipofuscin in the RPE, thickening of Bruch’s 
membrane, and the presence of drusen (reviewed in [3]). The 
onset and progression of AMD are strongly linked to comple-
ment system activation, a critical inflammatory component 
of the innate immune system (reviewed in [4]). Complement 
dysregulation, assessed with genetic polymorphisms and 
complement protein deposition in AMD retinas (reviewed in 
[4,5]), is a major risk factor for developing this disease.
Several population studies have reported an association 
between high body mass index (BMI) and AMD [6-10]. A 
higher BMI has also been associated with the progression 
to the more advanced forms of AMD, which can lead to 
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Purpose: Systemic increases in reactive oxygen species, and their association with inflammation, have been proposed as 
an underlying mechanism linking obesity and age-related macular degeneration (AMD). Studies have found increased 
levels of oxidative stress biomarkers and inflammatory cytokines in obese individuals; however, the correlation between 
obesity and retinal inflammation has yet to be assessed. We used the leptin-deficient (ob/ob) mouse to further our under-
standing of the contribution of obesity to retinal oxidative stress and inflammation.
Methods: Retinas from ob/ob mice were compared to age-matched wild-type controls for retinal function (electroreti-
nography) and gene expression analysis of retinal stress (Gfap), oxidative stress (Gpx3 and Hmox1), and complement 
activation (C3, C2, Cfb, and Cfh). Oxidative stress was further quantified using a reactive oxygen species and reactive 
nitrogen species (ROS and RNS) assay. Retinal microglia and macrophage migration to the outer retina and complement 
activation were determined using immunohistochemistry for IBA1 and C3, respectively. Retinas and sera were used for 
metabolomic analysis using QTRAP mass spectrometry.
Results: Retinal function was reduced in ob/ob mice, which correlated to changes in markers of retinal stress, oxidative 
stress, and inflammation. An increase in C3-expressing microglia and macrophages was detected in the outer retinas of 
the ob/ob mice, while gene expression studies showed increases in the complement activators (C2 and Cfb) and a decrease 
in a complement regulator (Cfh). The expression of several metabolites were altered in the ob/ob mice compared to the 
controls, with changes in polyunsaturated fatty acids (PUFAs) and branched-chain amino acids (BCAAs) detected.
Conclusions: The results of this study indicate that oxidative stress, inflammation, complement activation, and lipid 
metabolites in the retinal environment are linked with obesity in ob/ob animals. Understanding the interplay between 
these components in the retina in obesity will help inform risk factor analysis for acquired retinal degenerations, includ-
ing AMD.
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severe vision loss [11-13]. In obese patients, increased levels 
of oxidative stress biomarkers and inflammatory cytokines 
have been detected in plasma and muscle [14,15]. Longitu-
dinal studies and animals models also show that weight loss, 
dietary restriction, and exercise decrease these biomarkers 
[16]. Moreover, studies have shown that obesity induces 
oxidative stress, microglial activation, inflammation, and 
disruption of the blood–brain barrier in mouse brains [17-19]. 
A correlation between obesity and complement activation has 
been demonstrated in several tissues, including nerve biop-
sies from patients with diabetic polyneuropathy (reviewed in 
[20]), but little is known in ocular tissues. Although these data 
are tantalizing, the correlation between obesity and retinal 
inflammation is not fully understood.
In this study, we used an established genetic model of 
obesity, leptin-deficient (ob/ob) mice [21,22], to demonstrate a 
correlation between obesity, oxidative stress, and inflamma-
tion in retinal tissue. We showed that ob/ob animals exhibited 
lower retinal function and increased retinal stress, which 
was correlated with increased oxidative stress. No changes 
in the total number of microglia and macrophages in the ob/
ob mice were detected; however, an increased distribution 
of these immune cells in the outer retina indicated possible 
low-grade chronic retinal inflammation. We also showed that 
key components and regulators of complement activation (C2, 
Cfb, and Cfh) were modulated in ob/ob animals. Last, we 
showed changes in several metabolites involved in oxida-
tive stress and inflammation in the sera and retinas of ob/ob 
mice. This work lays a strong foundation for exploring the 
link between obesity and AMD and demonstrates a possible 
mechanistic role for complement activation in obesity, leading 
to the progression of inflammatory diseases, such as AMD.
METHODS
Experimental animals: All experiments were conducted in 
accordance with the ARVO Statement for Use of Animals in 
Ophthalmic and Vision Research and were approved by the 
Australian National University (ANU) Animal Experimenta-
tion Ethics Committee (Application ID: 2014/56). Leptin (ob/
ob) mutants and wild-type (wt) littermate control mice, on 
the C57BL/6J background, were used for the experiments 
at 70–90 postnatal days (animals obtained from Australian 
Phenomics Facility, ANU, Canberra, Australia; animal ID: 
6490). Animals were born and raised in a 12 h:12 h light-dark 
cycle of 5 lux with free access to food and water.
Electroretinography: Full-field scotopic electroretinography 
(ERG) was performed to assess the retinal function of the 
leptin-deficient (ob/ob) mice and the littermate controls. 
Animals were dark adapted overnight and anesthetized with 
an intraperitoneal injection of ketamine (100 mg/kg; Troy 
Laboratories, Sydney, Australia) and xylazine (10 mg/kg; 
Troy Laboratories). The pupils were dilated with 1% atro-
pine sulfate (Bausch + Lomb, Rochester, NY). ERG was 
performed using a single paradigm to elicit mixed responses 
(rod and cone) according to previously established method-
ology [23]. The a- and b-wave amplitudes were measured over 
a stimulus intensity range of −4.4 − 1.9 log cd·s·m-2. Data 
are expressed as the mean wave amplitude ± standard error 
of the mean (SEM; µV). Statistical significance (p<0.05) was 
determined using two-way analysis of variance (ANOVA) 
with Tukey’s multiple comparisons post-hoc test, using Prism 
5 software (GraphPad, La Jolla, CA).
Measurements of blood glucose and glycated hemoglobin: 
The wt and ob/ob mice were weighed, and peripheral blood 
was collected for measurements of blood glucose and glycated 
hemoglobin (HbA1c). Blood was collected in sterile EDTA-
treated tubes (#367838, BD Vacutainer; BD, Franklin Lakes, 
NJ) and stored at 4 °C. Blood glucose levels were measured 
using an Accu-Chek Performa blood glucose meter (Roche 
Diabetes Care, Sydney, Australia). HbA1c was measured 
using a Mouse Hemoglobin A1c Kit (#80310; Crystal Chem, 
Elk Grove Village, IL) according to the manufacturer’s 
instructions. HbA1c levels were read on a POLARstar Omega 
Spectrophotometer (BMG LABTECH, Ortenberg, Germany). 
Samples were averaged with n=8 per biological group, and 
statistical significance (p<0.05) was measured using a 
Student t test.
Tissue collection and preparation: Animals were eutha-
nized via cervical dislocation. For preparation of samples for 
histology, the left eye from each animal was enucleated with 
the superior surface marked and fixed in 4% paraformalde-
hyde for 3 h. Eyes were cryopreserved in 15% sucrose over-
night before embedding and cryosectioning at 12 µm in the 
parasagittal plane (superior–inferior). To enable comparison 
across animals, only histological sections containing the optic 
nerve (ON) head were used for analysis.
For preparation of molecular samples, the retina from 
the right eye of each animal was excised through a corneal 
incision and placed in RNAlater solution (Thermo Fisher 
Scientific, Waltham, MA) at 4 °C overnight and then stored 
at −80 °C. Total RNA was extracted from the retinal samples 
using a combination of an RNAqueous Micro Isolation Kit 
(Thermo Fisher Scientific) and TRIzol (Thermo Fisher Scien-
tific) according to the manufacturer’s protocol. The concen-
tration and purity of the RNA samples were determined using 
an ND-1000 spectrophotometer (Thermo Fisher Scientific).
Immunohistochemistry: Sections were incubated in 10% 
normal goat serum (Sigma-Aldrich, St. Louis, MO) for 1 h 
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at room temperature (RT), followed by overnight incubation 
with the primary antibodies (Table 1) at 4 °C. Antigen retrieval 
(RevealIt-Ag; ImmunoSolutions, Brisbane, Australia) was 
performed only for the IBA1 antibody, before blocking with 
normal goat serum, for 1 h at 37 °C. All sections were incu-
bated with appropriate fluorophore-conjugated secondary 
antibodies for 4 h at RT, before staining with bisbenzimide 
to identify the cellular layers and mounting with Aqua-Poly/
Mount (Thermo Fisher Scientific). Visualization of immuno-
fluorescence and image acquisition were performed using an 
A1+ confocal microscope (Nikon, Tokyo, Japan). The IBA1 
antibody was conjugated to Alexa Fluor 647 (Thermo Fisher 
Scientific) for colocalization of the IBA1 and C3 antibodies 
(raised in rabbits).
IBA1-positive microglia and macrophages were counted 
across the retinal cryosections (n=6 per experimental group). 
For each animal, two retinal sections were counted, and all 
values averaged together and analyzed with a Student t test. 
The outer nuclear layer (ONL) thickness was calculated by 
counting the number of photoreceptor rows (500 µm from the 
ON on the superior side of the retina). Three counts for each 
section (n=5 animals per group) were used in the analysis, 
and the averages taken and compared using a Student t test.
Analysis of gene expression: Following purification of RNA, 
cDNA was synthesized using the Tetro cDNA Synthesis 
Kit (Bioline, London, UK) according to the manufacturer’s 
protocol. A 20 μl reaction mixture was prepared using 1 
μg of purified RNA, 500 ng Oligo dT primer, and 200 U 
reverse transcriptase. Quantitative real-time PCR (qPCR) 
was performed using mouse-specific TaqMan hydrolysis 
probes (Table 2; Thermo Fisher Scientific) and TaqMan 
Gene Expression Master Mix (Thermo Fisher Scientific). 
Amplification of each sample was performed in technical 
duplicates, performed using a QuantStudio 12 K Flex 
RT–PCR machine (Applied Biosystems, Warrington, PA). 
Data were analyzed using Expression Suite v1.0.3 software 
(Thermo Fisher Scientific), and the analysis was performed 
using the comparative cycle threshold (Ct) method (ΔΔCt). 
Values are presented as a log twofold change. Target genes 
were normalized to two reference genes, glyceraldehyde-
3-phosphate dehydrogenase (Gapdh) and actin beta (Actb). 
Statistical significance (p<0.05) was determined using 
one-way ANOVA with Tukey’s multiple comparison post-test 
(n=3 per experimental group).
ROS and RNS assays: To measure reactive oxygen species 
(ROS) and reactive nitrogen species (RNS), both retinas from 
each animal were harvested and immediately homogenized 
in 500 µl of 0.1% Tween-20 in PBS (1X; 155 mM NaCl, 1 
mM KH2PO4, 3 mM Na2HPO4-7H2O, pH 7.4), spun down 
at 10,000 ×g for 5 min, and the supernatant removed. Fifty 
microliters of each supernatant was used in the OxiSelect 
In Vitro ROS/RNS Assay Kit (Cell Biolabs, San Diego, CA) 
according to the manufacturer’s instructions to measure the 
ROS and RNS content of the isolates from freshly harvested 
retinas. The fluorescence was measured at 530 nm using a 
plate reader (Tecan Infinite Pro 200, Männedorf, Switzer-
land). Samples were averaged with n=6 per biological group 
and statistical significance (p<0.05) was measured.
FACS isolation of primary microglia: Isolation of rat retinal 
microglia was performed using fluorescence-activated cell 
sorting (FACS) following a modified protocol previously 
published [24,25]. Retinas were collected from dim-reared 
adult (P90) Wistar rats through a corneal incision and 
placed into chilled Hank’s Balanced Salt Solution (HBSS). 
Retinas were then mechanically dissociated with a scalpel 
blade followed by enzymatic digestion using a 0.2% papain 
digestion cocktail as previously described [24,25]. Samples 
were then neutralized and resuspended in staining buffer 
containing a Phycoerythrin/Cyanine7 (PE/Cy7)-conjugated 
anti-rat antibody to CD11b (Biolegend, San Diego, CA) 
and incubated for 40 min at 4 °C. Following staining, the 
cells were washed, resuspended, and filtered before sorting 
Table 1. Primary and secondary anTibodies used for immunohisTochemisTry.
Antibody
Catalogue 
Number Host Dilution Source
IBA1 019-19741 Rabbit 1:500 Wako Pure Chemical Industries (Osaka, Japan)
GFAP Z0334 Rabbit 1:500 Dako (Sydney, Australia)
C3 ab11887 Rabbit 1:500 Abcam (Cambridge, United Kingdom)
Rhodopsin AB9279 Rabbit 1:500 Merck-Millipore (Darmstadt, Germany)
Alexa Fluor 
488 A31627 Goat 1:1000 Thermo Fisher Scientific (Waltham, MA)
Alexa Fluor 
594 A31631 Goat 1:500 Thermo Fisher Scientific
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through a BD FACSAria II (BD Biosciences, Franklin Lakes, 
NJ). Approximately 4,000 cells were sorted per sample. 
Isolated microglia were cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS; Sigma-Aldrich), 1% antibiotic-antimy-
cotic (Thermo Fisher Scientific), 3% L-glutamine (Thermo 
Fisher Scientific), and a granulocyte-macrophage colony 
stimulating factor (GM-CSF, 5 ng/ml; Stem Cell Technolo-
gies, Vancouver, Canada) with 5% CO2 at 37 °C. Media was 
replaced every 3–4 days until cells reached 80% confluency.
Validation of primary microglia using PCR: Standard PCR for 
validation of microglial cell markers was performed, testing 
for the absence of glial fibrillary acidic protein (Gfap) and 
rhodopsin (Rhod). The PCR reaction mixture was prepared 
using the MyTAQ kit (Bioline). To each reaction mixture, 10 
μl of 5X MyTAQ Reaction Buffer, 0.25 μl of MyTAQ Poly-
merase, 0.5 μl of cDNA template (40 ng/μl), 1 μl of forward 
primer, 1 μl of reverse primer, and 37.25 μl of DNase-free 
water was added. The primers used for amplification of Gfap 
are as follows: forward primer 5′-AGT CGC TGG AGG 
AGG AGA T-3′ and reverse primer 5′-TGA GGT GGC CTT 
CTG ACA-3′. The final product length of Gfap was 642 bp. 
The primers used for amplification of Rhod are as follows: 
forward primer 5′-CTT CCC CAT CAA CTT CCT C-3′ and 
reverse primer 5′-CCC AGT GGR TTC TTG CC-3′. The final 
product length of Rhod was 834 bp. Samples were amplified 
in a thermocycler for 1 min at 95 °C followed by a further 15 
s at 95 °C, 15 s at 60 °C, 10 s at 72 °C, and finally, a further 
1 min at 72 °C. Samples were then run on a 1% agarose gel 
for 40 min.
Mass spectrometry analysis: The ob/ob and control mice 
(n=6) were randomly culled with cervical dislocation, and 
blood was collected after decapitation. Serum, obtained 
after blood clotting at 4 °C, was stored at −80 °C until 
analysis. Both retinas from each animal were collected in a 
0.5 ml chilled Precellys tube (Bertin Corp, Rockville, MD) 
prefilled with ceramic beads. To each retina sample, 175 μl 
of a cold mixture of methanol:water (140:35, v:v) was added 
for tissue homogenization and metabolite extraction. Tissue 
was homogenized using a Precellys 24 homogenizer (Bertin 
Corp) with two cycles of grinding (40 s at 4440 ×g, followed 
by 30 s at 3780 ×g) at 4 °C. The resulting homogenate was 
centrifuged at 16,000 ×g for 5 min, and 140 µl of the superna-
tant was transferred to a second tube and spin-dried. Extracts 
were stored at −80 °C until needed for metabolomics analysis.
Targeted quantitative metabolomics analysis was 
performed using the AbsoluteIDQ p180 kit (Biocrates Life 
Sciences AG, Innsbruck, Austria) and the QTRAP 5500 
(SCIEX, Framingham, MA) mass spectrometer (MS). This 
enables quantification of up to 188 endogenous metabolites, 
including lipids and polar molecules. Flow injection analysis 
(FIA-MS/MS) was used for quantifying carnitine, acyl-
carnitines, lipids, and sugar, while liquid chromatography 
(LC) was employed to separate amino acids and biogenic 
amines before MS quantification. All reagents used in this 
analysis were of LC-MS grade (VWR, Radnor, PA; Merck, 
Kenilworth, NJ). For retinal sample preparation, 30 µl of 
methanol was added to each sample and vortexed thoroughly 
for 5 min. Ten microliters of each retinal and serum sample 
was mixed with isotope-labeled internal standards and loaded 
on the 96-well plate. Metabolites were resuspended in ammo-
nium acetate after filter spots had been dried under nitrogen 
flow and derivatized with phenylisothiocyanate (only for the 
quantification of amino acids and biogenic amines). Extracts 
Table 2. Taqman hydrolysis Probes used for qPcr.
Gene Symbol Gene Name Catalog Number
Entrez Gene 
ID
Gfap Glial fibrillary acidic protein Mm01205647_g1 14580
Cntf Ciliary neurotrophic factor Mm00446376_m1 12803
Fgf2 Fibroblast growth factor 2 Mm01285715_m1 14173
C3 Complement component 3 Mm00437858_m1 12266
C2 Complement component 2 Mm00442726_m1 12263
Cfb Complement factor B Mm00433918_g1 14962
Cfh Complement factor H Mm01299248_m1 12628
Gpx3 Glutathione peroxidase 3 Mm00492427_m1 14778
Hmox1 Heme oxygenase 1 Mm01536933_m1 15368
Gapdh Glyceraldehyde-3-phosphate dehydrogenase Mm99999915_g1 14433
Actb Actin, Beta Mm01205647_g1 11461
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were diluted with MS running solvent (MilliQ water for the 
high-performance liquid chromatography [HPLC] assay 
or a methanol solution for the FIA assay) before the FIA 
and LC-MS/MS analyses. Quality controls (QCs) at three 
concentrations (low, medium, and high) were included in the 
analysis. Analyst software (SCIEX) was used for MS data 
collection, and MetIDQ software (Biocrates Life Sciences 
AG) was used to control the entire assay workflow.
Before statistical analysis was performed, the raw data 
were examined to eliminate metabolites not accurately 
measured; for example, metabolites with a concentration 
outside the lower limit of quantitation (LLOQ) and the 
upper limit of quantitation (ULOQ). When more than 20% 
of concentration values were not accurately measured, 
the metabolite was not considered for statistical analysis. 
Multivariate analysis was performed using unit variance-
scaled data. Principal component analysis (PCA) was used 
to detect sample groups and outliers. An orthogonal partial 
least-squares discriminant analysis (OPLS-DA), which is a 
supervised pattern recognition method, was then performed 
to maximize variation between groups and to determine vari-
ables contributing to this variation. The quality of models 
was validated by determining two parameters: R2 (goodness 
of fit) and cumulated Q2 (Q2cum, goodness of prediction). 
A threshold of 0.5 is widely accepted in classifying models 
as having good (Q2cum ≥0.5) or poor (Q2cum<0.5) predic-
tive capabilities. The risk of overfitting and robustness was 
assessed with the intercept of the permutation plot. This inter-
cept reflects the predictive capabilities (permQ2) of a model 
having the same number of components (or latent variables) 
and the same X matrix (metabolites) but a randomly permuted 
y vector (scrambled y) of response variables (that is, at the 
intercept, there is no correlation between the original y vector 
and the permuted y vector). Non-overfitted models have a 
negative permQ2 value [26]. If a predictive model (i.e., Q2cum 
≥0.5) was obtained, the top variables were selected based on 
the variable importance for the projection (VIP) and loading 
values scaled as correlation coefficients (pcorr). VIP values 
summarize the importance of each variable for the OPLS-DA 
model, while the loadings are indicators of the relationship 
between the y variables (the leptin genotype) and the X 
variables (the matrix of the measured metabolites). Variables 
that have a VIP value higher than 1 are considered important 
for group discrimination in predictive models [27]. Plotting 
VIP versus pcorr values (“volcano” plot) enables selection 
of important variables in partial least-squares (PLS) models. 
Multivariate data analysis was conducted using SIMCA-P 
v.14.0 (Umetrics, Umeả, Sweden).
RESULTS
Increased bodyweight of ob/ob is correlated to changes in 
retinal function and stress: Mice deficient in the leptin gene 
(ob/ob) were statistically significantly higher in bodyweight 
than littermate wt control mice (p<0.05, Figure 1A) and 
showed no change in blood glucose or glycated hemoglobin 
levels (Figure 1B,C). Analysis of the ONL thickness (Figure 
1D,E) indicated that there were no changes in the number 
of photoreceptor in the ob/ob animals compared to the wt 
animals (p>0.05). Despite the lack of change in the photore-
ceptor layer size, there was a statistically significant change 
in retinal function (ERG); the ob/ob animals had a reduced 
a-wave (p<0.05, Figure 1F) and b-wave (p<0.05, Figure 1G) 
with the largest difference at the highest light intensity (1.9 
Log cd.s/m2, Figure 1H). Assessment of cone function also 
indicated a statistically significant reduced response in the 
ob/ob animals at 1.9 Log cd.s/m2 (Figure 1I). Assessment of 
general retinal stress markers indicated altered expression of 
GFAP via qPCR and immunohistochemistry (Figure 1J–L). 
Gene expression analysis showed a statistically significant 
1.5-fold change in GFAP in the ob/ob mice (p<0.05). There 
were no changes in the neuroprotective factors Cntf and Fgf2.
Changes in inflammation and complement in the ob/ob mice: 
The overall number of retinal IBA1-positive microglia and 
macrophages did not change in the ob/ob mice (p>0.05, 
Figure 2A); however, there were noticeable changes in the 
distribution of IBA1-positive cells in the ob/ob retinas (Figure 
2B–G). The wt animals showed IBA1-positive labeling 
primarily in the inner plexiform layer (IPL) with some cell 
processes extending into the ONL. No IBA1-positive nuclei 
were observed in the outer retinas of the wt control mice 
(Figure 2B). In contrast, the ob/ob mice had IBA1-positive 
cell nuclei in the ONL, with cell processes extending into 
the photoreceptor outer segments (OS) and the RPE (Figure 
2C–G).
No changes in the expression of C3 were observed in the 
ob/ob animals (Figure 3A), although statistically significant 
increases in expression, relative to the wt control mice, of C2 
in the classical pathway of complement activation (eightfold 
increase, p<0.05) and Cfb in the alternative pathway (3.5-fold 
increase, p<0.05) were evident (Figure 3A). Cfh, a key nega-
tive regulator of the alternative pathway, was downregulated 
(twofold decrease, p<0.05). Immunohistochemistry for C3 
(Figure 3B–E) showed no C3 expression in the wt retinas 
(Figure 3B) but showed C3 deposition in the outer retinas 
of the ob/ob mice (Figure 3C–E). Colocalization of C3 
retinal expression with IBA1 (Figure 3F–N) showed a clear 
association between C3 expression and IBA1-positive cells 
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Figure 1. Altered bodyweight was correlated with decreased retinal function and increased GFAP expression in leptin-deficient (ob/ob) mice. 
A: The ob/ob mice showed an approximate doubling in bodyweight (grams) at 90 postnatal days compared to the wild-type (wt) littermate 
controls (p<0.05, n=8). B, C: We observed no statistically significant changes in blood glucose (B) or glycated hemoglobin (HbA1c, C) 
levels in the ob/ob mice compared to the littermate wt control mice. D, E: No changes in outer nuclear layer (ONL) thickness were detected 
across the retina (B, n=5), with no difference between the superior and inferior retina observed (C, n=5). F–H: Functional studies showed 
a statistically significant decrease in a- (F) and b-wave (G) amplitudes in the ob/ob mice compared to the wt control mice. This difference 
was most noticeable at the highest stimulus intensity of 1.9 Log cd.s/m2 (H, n=3 wt, n=6 ob/ob). I: Photopic electroretinography (ERG; 
cones) showed a statistically significant difference in function between the wt control and ob/ob animals at 1.9 Log cd.s/m2 (F, n=6 wt, 
n=6 ob/ob). J: In the ob/ob mice compared to the wt control mice, a statistically significant increase was determined for the retinal stress 
marker Gfap (p<0.05, n=9), but no statistically significant change was detected for the retinal stress markers Cntf and Fgf2 (n=9). K, L: 
Immunohistochemistry for GFAP showed increased labeling (arrowheads) in the ganglion cell layer (GCL) and the inner plexiform layer 
(IPL) in the ob/ob retinas (K) compared to the wt control retinas (L). Statistical analysis was performed using a Student t test (A–D, I, J) 
and a two-way ANOVA with uncorrected Fisher’s least significant difference (LSD) post-test (F–H). * indicates a statistical significance 
and a p value of less than 0.05. INL, inner nuclear layer. Scale bars = 50 µm. Error bars are displayed as standard error of the mean (SEM).
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indicating microglia and macrophage production of C3 in the 
outer retinas (photoreceptors and RPE) of ob/ob mice.
Increases in oxidative stress in ob/ob mice lead to comple-
ment activation: There was a clear and statistically signifi-
cant increase in the number of ROS and RNS (Figure 4A) in 
the ob/ob mouse retinas compared to the wt control mouse 
retinas, with a 70% increase in activity detected with the 
ROS/RNS assay (p<0.05). Key oxidative stress genes were 
differentially regulated in the ob/ob retinas compared to the 
wt control retinas (p<0.05, Figure 4B), including the detoxi-
fying hydrogen peroxide (H2O2) gene glutathione peroxidase 
3 (Gpx3) and the antioxidant heme oxygenase 1 (Hmox1) 
gene. Primary microglia (isolated and cultured from whole 
rat retinas) were validated (Appendix 1) and treated with 1 
mM H2O2 for 1 h to induce oxidative stress (Figure 4C,D), 
where cells exhibited no ramified processes. The expression 
of several complement activator and regulator genes was 
analyzed following H2O2 treatment (Figure 4E). Although 
we detected a decrease in C3 and Cfh expression, C2 and Cfb 
were increased (p<0.05).
Metabolomics of serum and retina in ob/ob mice: After vali-
dation of the quality controls, 128 metabolites in the serum 
and 136 metabolites in the retinal extract were retained for 
multivariate statistical analysis. PCA showed a clear grouping 
of samples according to the leptin genotype without outliers 
(Figure 5A). This separation was improved with the super-
vised OPLS-DA algorithm (Figure 5B), yielding a model 
explaining the variance in the X matrix (R2X=0.76) and 
in the y vector of the responses (R2Y=0.97) and with good 
predictive capabilities (Q2cum=0.82). The risk of overfitting 
was low as indicated by the negative permQ2 (permQ2=–
0.62). The top discriminant metabolites for the wt and ob/ob 
serum were identified in the volcano plots as those having the 
greatest VIP (i.e., VIP>1) and absolute pcorr values (Figure 
5C). In the ob/ob mouse serum, three metabolites were 
Figure 2. Changes in morphology and location of IBA1-positive microglia and macrophages in ob/ob mice. A–C: There was no change in the 
overall numbers of IBA1-positive cells between the ob/ob retinas and the wild-type (wt) control retinas (A), with an occasional IBA1-positive 
cell process found in the outer nuclear layer (ONL) in the wt control mice (B) and ob/ob (C) mice. D–G: However, several IBA1-positive 
cells were found with nuclei in the outer retina in the ob/ob mice only, with processes extending into the outer segments (OS, D–F) and RPE 
(G). No IBA1-positive nuclei were observed in the outer retinas (ONL-RPE) of the wt control animals. Statistical analysis was performed 
using a Student t test. NS indicates no statistical significance (p>0.05). GCL, ganglion cell layer; INL, inner nuclear layer. Scale bars = 50 
µm. Error bars are displayed as standard error of the mean (SEM).
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Figure 3. Complement activation in ob/ob retinas. A: Statistically significantly altered gene expression of C2, Cfb, and Cfh (p<0.05, n=8–9) 
was detected in the ob/ob retinas compared to the wild-type (wt) control retinas, which are all involved in complement activation. No 
statistically significant difference was detected in C3 gene expression between the groups (n=12). B–E: Immunohistochemistry for C3 in 
the wt control retinas showed no C3 expression in any of the retinal sections analyzed (B, n=8). However, C3 expression (arrowheads) was 
detected in several cells in the ob/ob retinas, in the outer retina (C, E) and the outer plexiform layer (OPL, D). F–N: Colocalization of C3 
(green) and IBA1 (purple) was observed in the ob/ob outer retinas (F–H), the OPL (I–K) and within the outer segments (OS, L and M). 
Statistical analysis was performed using a Student t test. * indicates a statistical significance of p<0.05. INL, inner nuclear layer; ONL, 
outer nuclear layer; RPE, retinal pigment epithelium. Scale bars = 50 µm. Error bars are displayed as standard error of the mean (SEM).
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decreased, and 47 metabolites were increased compared to 
the wt control mouse serum.
PCA for retinal samples showed no outliers but a less 
clear separation between the leptin-deficient mice and the 
control mice (Figure 5D). However, the OPLS-DA method 
improved group discrimination (Figure 5E) in a model 
characterized by a correct approach of X and y variance 
(R2X=0.82 and R2Y=0.98, respectively), good predictive 
capabilities (Q2cum=0.70), and a low risk of overfitting 
(permQ2=–0.68). The top discriminant metabolites for the 
serum and retina models are identified in the volcano plots as 
those having the greatest VIP (i.e., VIP>1) and absolute pcorr 
values (Figure 5F). In the ob/ob retinas, ten metabolites were 
decreased, and 48 metabolites were increased compared to 
the wt control retinas.
In the ob/ob mice, the expression of several metabolites 
was altered compared to the wt control mice in the serum 
and retinal samples concurrently (Table 3), as well as the 
metabolites that changed in ob/ob serum only (Table 4) 
and the ob/ob retinas only (Table 5). This included several 
Figure 4. Increased oxidative stress 
correlates to changes in complement 
genes in ob/ob mice. A: A compar-
ison of retinas isolated from the 
wild-type (wt) control mice to the 
retinas of the ob/ob mice indicated 
a statistically significant increase in 
reactive oxygen species (ROS) and 
reactive nitrogen species (RNS) 
production in the ob/ob retina 
(p<0.05, n=6). B: Gene expression 
analysis showed differential expres-
sion of oxidative stress markers in 
the ob/ob retinas compared to the 
wt control retinas, with increased 
Gpx3 and decreased Hmox1 expres-
sion detected (p<0.05, n=10). C–D: 
Primary microglial cells treated 
with 1 mM H2O2 exhibited no rami-
fied processes, with slight morpho-
logical changes observed compared 
to controls. E: Gene expression 
analysis detected a statistically 
significant increase in C2 and Cfb 
expression (p<0.05, n=3), while 
the expression of C3 and Cfh was 
decreased following 1 mM H2O2 
incubation for 1 h (p<0.05, n=3). 
Statistical analysis was performed 
using a Student t test. * indicates a 
p value of less than 0.05. Scale bars 
= 50 µm. Error bars are displayed as 
standard error of the mean (SEM).
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amino acids, such as glutamate, isoleucine, leucine, and 
tryptophan, as well as lipid molecules, such as lyso-
phosphatidylcholine, diacyl phosphatidylcholine, acyl-
alkyl phosphatidylcholine, hydroxy-sphingomyelin, and 
sphingomyelin.
DISCUSSION
The association between obesity, inflammation, and retinal 
degenerative diseases, including AMD, has been shown in 
humans [2,8,28] and animal models [29-31]. However, the 
mechanisms underlying the increased risk of retinal degener-
ation in obesity, as well as the roles played by oxidative stress 
and complement activation, are unclear. In this study, we 
demonstrate a correlation between obesity, oxidative stress, 
Figure 5. Multivariate analysis of 
metabolomics data from ob/ob and 
wt control mouse sera and retinas. 
A: Principal component analysis 
(PCA, PC1 versus PC2) of the 
serum samples showed a good sepa-
ration between the ob/ob (green) 
and wild-type (wt) control (blue) 
mice along the second principal 
component (PC2). B: Orthogonal 
partial least-squares discriminant 
analysis (OPLS-DA) scatterplot 
displaying clear between-group 
separation along the predictive 
component (tp) in serum. C: 
Volcano plot showing top discrimi-
nant metabolites (highest variable 
importance for the projection 
(VIP) and pcorr values) between 
the ob/ob and wt control mice. 
Metabolites with a VIP value >1 
are marked in red. Three metabo-
lites decreased in the ob/ob mouse 
serum, and 47 increased compared 
to the wt control mice. D: Principal 
component analysis of the retinal 
samples (PC1 versus PC2) shows 
no outliers but a less clear separa-
tion between the ob/ob (green) and 
wt control retinal samples (blue). E: 
OPLS-DA scatter plot displaying 
clear between-group separation 
along the predictive component 
(tp). F: Volcano plot showing top 
discriminant metabolites (highest 
VIP and pcorr values) in between-
group discrimination. Metabolites 
with a VIP value >1 are marked in 
red. Ten metabolites decreased in the ob/ob mouse retinas, and 48 increased compared to the wt control retinas. PCA, principal component 
analysis; PC1, first principal component; PC2, second principal component; tp, predictive component in the OPLS-DA model; to, orthogonal 
component in the OPLS-DA model; VIP, variable importance for the projection; pcorr, scaled loading values. AA, amino acids; BA, biogenic 
amine compounds; CC, carnitine compounds; Glu, glutamate; LysoPC, lyso-phosphatidylcholine; PC aa, diacyl phosphatidylcholine; PC ae, 
acyl-alkyl phosphatidylcholine; SM, sphingomyelin; SM(OH), hydroxy sphingomyelin.
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and inflammation in retinal tissue. First, we showed that the 
ob/ob animals exhibited lower retinal function, which was 
correlated with an increase in general retinal stress and oxida-
tive stress, compared with the wt control animals. Second, 
we demonstrated a change in the distribution of microglia 
and macrophages into the outer retina of the ob/ob animals, 
a hallmark of many retinal degenerations, including AMD. 
Third, the data showed that key regulators of the complement 
cascade (C2, Cfb, and Cfh) are regulated toward complement 
activation in ob/ob mice. Last, we showed that several lipid 
metabolites were differentially regulated in the serum and 
retinal samples taken from the ob/ob animals. This work lays 
strong foundations for exploring the link between obesity 
and AMD and demonstrates a possible mechanistic role for 
complement activation in obesity leading to the progression 
of AMD.
Modulation of oxidative stress and inflammation in ob/ob 
animals: In AMD, the balance between age-related stress or 
damage and the repair or remodeling functions of the local 
retinal immune system may be disturbed due to the altered 
regulation of immune processes (genetic predisposition) or 
excessive damage due to lifestyle factors (reviewed in [32]). 
Obesity may contribute to inflammation in the retina where 
symptoms progress with age, and promote the onset and 
progression of AMD. The present data suggest that obesity 
induces low-level oxidative stress in the retina, which can 
lead to chronic retinal inflammation over time [3].
Many facets of retinal aging, including a heightened 
inflammatory response, have been attributed to the increased 
production of ROS (reviewed in [33]), where it is hypoth-
esized that regulation of ROS by antioxidant systems has the 
potential to prevent the progression of AMD [34]. The accu-
mulation of ROS in fatty tissue is an important pathogenic 
Table 3. meTaboliTes ThaT changed in ob/ob serum and reTinas.
Group Metabolite p corr
Serum 
VIP p corr
Retina 
VIP
Amino Acids Glutamate -0.62848 1.07062 0.48521 1.09397
 Isoleucine 0.789994 1.33623 0.585773 1.28116
 Leucine 0.810948 1.34441 0.520356 1.19146
 Tryptophan 0.878639 1.45113 0.676211 1.37675
lyso-phosphatidylcholine lysoPC a C16:0 0.793288 1.36093 0.727204 1.35957
 lysoPC a C16:1 0.80441 1.36459 0.75586 1.40434
 lysoPC a C18:0 0.711927 1.23264 0.439303 1.00424
 lysoPC a C18:1 0.779201 1.32028 0.739892 1.37745
 lysoPC a C20:3 0.671639 1.17138 0.545529 1.13244
 lysoPC a C20:4 0.657354 1.14978 0.707013 1.3408
diacyl-phosphatidylcholine PC aa C32:0 0.746435 1.23377 -0.58743 1.16226
 PC aa C36:1 0.864564 1.43952 -0.5154 1.07721
 PC aa C36:4 0.849357 1.43239 0.580902 1.18811
 PC aa C36:5 0.718598 1.26584 0.600343 1.20925
 PC aa C38:3 0.865695 1.43961 -0.67882 1.27696
 PC aa C38:5 0.882577 1.47481 0.552574 1.14977
 PC ae C34:1 0.525742 1.05543 -0.45293 1.00707
acyl-alkyl 
phosphatidylcholine PC ae C36:4 0.614955 1.16171 0.584345 1.18598
 PC ae C36:5 0.534883 1.07635 0.800319 1.4662
 PC ae C38:0 0.746339 1.30686 0.574565 1.18106
 PC ae C40:6 0.60895 1.11477 -0.59195 1.15981
 SM (OH) C14:1 0.65887 1.18889 0.741898 1.38954
hydroxy-sphingomyelin SM C16:0 0.79134 1.35024 0.781304 1.44328
sphingomyelin SM C18:1 0.767981 1.30684 0.783581 1.43465
 SM C20:2 0.702222 1.17311 0.511015 1.04732
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mechanism in the development of obesity [15]. The present 
data suggest that an increase in ROS and general retinal 
stress in the ob/ob animals mediates retinal inflammation 
in obesity. We showed a decrease in retinal function in the 
ob/ob animals, although no difference in photoreceptor layer 
thickness was observed. However, we were able to detect an 
increase in general retinal stress (GFAP) and oxidative stress 
(Gpx3 and Hmox1), which was correlated with increased ROS 
and RNS production and microglia and macrophage migra-
tion to the outer retina in the ob/ob mice. It is likely that low-
level changes in oxidative stress lead to an accumulation of 
ROS and RNS over time, prompting a change in the inflam-
matory status of the ob/ob retina. We have previously shown 
a correlation between oxidative stress and inflammation, and 
decreased retinal function in a model of retinal inflammation 
[23]. Despite the lack of photoreceptor cell death in the ob/ob 
retinas, lower retinal function indicates a low-level change in 
retinal homeostasis and a move toward a retinal environment 
conducive to degeneration.
Retinal complement activation in ob/ob animals: In this 
study, the increase in complement activators C2 and Cfb, 
and decrease in negative regulator Cfh in the ob/ob mouse 
retinas indicates that complement activation may be linked to 
obesity-induced oxidative stress and inflammation. Microglia 
and macrophages are a key source of complement synthesis 
in retinal aging and degeneration, contributing to the progres-
sion of retinal damage [35-38]. Numerous studies have shown 
that the recruitment of microglia, the resident immune cells of 
the retina, exacerbates retinal degeneration in animal models 
of AMD [25,39,40], diabetic retinopathy [41,42], and glau-
coma [43]. In the ob/ob animals, we found migration of retinal 
microglia into the outer retina associated with C3 deposition 
and upregulation of complement activation. Further, induc-
tion of oxidative stress in primary isolated microglia resulted 
in a similar increase in complement activation, including an 
increase in C2 and Cfb, and a decrease in Cfh. Together, these 
results demonstrate obesity-related complement activation in 
the retina, mediated by microglia and macrophages.
Table 4. meTaboliTes ThaT changed in ob/ob serum only.
Group Metabolite p corr Serum VIP p corr Retina VIP
Amino Acids Valine 0.7848 1.31971 0.204573 0.802158
Biogenic Amines Carnosine -0.7523 1.25347 0.350184 0.905499
 Creatinine -0.6438 1.16845 0.091917 0.624234
Carnitines Butyryl-L-carnitine 0.70934 1.15011 0.118303 0.747896
diacyl-phosphatidylcholine PC aa C32:1 0.86028 1.41343 0.336775 0.905788
 PC aa C32:2 0.53414 1.04884 0.253623 0.834408
 PC aa C34:1 0.85739 1.43615 0.321684 0.895455
 PC aa C34:2 0.58028 1.11623 -0.26064 0.820304
 PC aa C34:4 0.48431 1.03834 0.110975 0.739271
 PC aa C36:2 0.55357 1.10851 -0.06894 0.725665
 PC aa C36:3 0.80184 1.38013 -0.40703 0.949685
 PC aa C36:6 0.59324 1.13294 -0.25253 0.816078
 PC aa C38:4 0.8806 1.45839 0.009421 0.719502
 PC aa C38:6 0.84708 1.42543 0.136406 0.760069
 PC aa C40:4 0.54142 1.06771 -0.25239 0.81383
 PC aa C40:5 0.82655 1.39243 -0.15522 0.751357
 PC aa C40:6 0.88936 1.47078 -0.08527 0.720281
acyl-alkyl phosphatidylcholine PC ae C38:3 0.45492 1.01024 0.181811 0.784762
 PC ae C38:4 0.64208 1.1811 -0.10392 0.72364
 PC ae C38:5 0.51624 1.06876 0.417416 0.97917
 PC ae C40:3 0.57574 1.1178 0.065519 0.729058
 PC ae C40:5 0.73397 1.29608 0.078598 0.72589
 PC ae C42:5 0.75062 1.31289 0.034568 0.72336
hydroxy-sphingomyelin SM (OH) C22:1 0.65348 1.12435 -0.18174 0.737934
sphingomyelin SM C18:0 0.82008 1.35581 0.234547 0.795889
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Although C3 deposition by microglia and macrophages 
was detected with immunohistochemistry in the outer retinas 
of the ob/ob mice, we also found no change in the levels of 
retinal C3 gene expression in ob/ob mice. Similarly, in the 
H2O2-stimulated primary microglia, we observed upregula-
tion of C2 and Cfb in response to H2O2 stimulation—indica-
tive of complement system activation—but decreased C3 and 
Cfh gene expression. This finding is unexpected in light of 
data from other models of retinal damage we have investi-
gated, in which C3 gene expression patterns mirrored the 
translation to protein [36-38]. It is possible that the addition 
of GM-CSF during the microglial culture process may have 
an effect on complement activation in vitro, or that changes 
in post-transcriptional regulation of C3 synthesis may explain 
Table 5. meTaboliTes ThaT changed in ob/ob reTinas only.
Group Metabolite p corr Serum VIP p corr
Retina 
VIP
Amino Acids Arginine 0.517273 0.883953 0.37412 1.01052
 Phenylalanine 0.577612 0.968697 0.60658 1.29648
 Proline 0.572147 0.967029 0.71031 1.42675
 Serine 0.089818 0.356669 0.58207 1.24897
 Threonine 0.558031 0.961585 0.66561 1.36318
 Tyrosine 0.497811 0.859313 0.42847 1.07025
Biogenic Amines Histamine 0.133188 0.435193 0.60836 1.2321
Carnitines L-Carnitine -0.13254 0.667314 0.5999 1.20156
 Octadecenoyl-L-carnitine 0.079876 0.435358 0.44321 1.00964
 Valeryl-L-carnitine - - 0.52958 1.11339
lyso-phosphatidylcholine lysoPC a C18:2 0.196199 0.726949 0.78953 1.44872
 lysoPC a C24:0 -0.09497 0.789297 0.48052 1.06013
 lysoPC a C26:1 0.407743 0.797227 0.43516 1.00356
 lysoPC a C28:0 0.179581 0.736869 0.48465 1.05785
 lysoPC a C28:1 0.254284 0.709321 0.44365 1.018
diacyl-phosphatidylcholine PC aa C24:0 0.074606 0.731657 0.51499 1.08192
 PC aa C28:1 0.461476 0.905075 0.56906 1.16167
 PC aa C38:1 -0.39672 0.961062 -0.7301 1.35367
 PC aa C40:3 -0.22636 0.809281 0.44567 1.01657
acyl-alkyl 
phosphatidylcholine PC ae C30:1 0.22234 0.558391 0.45905 1.0303
 PC ae C32:2 0.131107 0.673476 0.79237 1.45483
 PC ae C34:0 0.116072 0.799204 -0.6638 1.27003
 PC ae C34:2 -0.29146 0.823435 0.73692 1.38054
 PC ae C34:3 -0.38166 0.942243 0.43546 1.00916
 PC ae C36:1 0.073059 0.788656 -0.4865 1.047
 PC ae C40:1 0.374539 0.936429 -0.6445 1.21146
 PC ae C42:3 0.395941 0.958794 0.46826 1.05383
 PC ae C44:3 0.074266 0.792551 0.45358 1.03745
 PC ae C44:5 0.058851 0.756676 0.60351 1.21601
 PC ae C44:6 -0.14726 0.800369 0.86332 1.55599
sphingomyelin SM C16:1 0.190844 0.776799 0.73965 1.37982
 SM C24:0 0.357199 0.879899 -0.4503 1.00622
 SM C24:1 0.216329 0.66833 0.46169 1.02116
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the observed C3 deposition in the ob/ob mice. Further inves-
tigations are in progress to better understand these dynamics 
of C3 regulation.
Leptin-deficient ob/ob animals are hyper-responsive to 
infection and inflammation, suggesting an alternative role 
for leptin in regulating inflammation [44-47]. The effects 
of leptin in the retina have not been well studied; however, 
research has suggested that higher levels of serum leptin are 
inversely associated with AMD [48,49] suggesting a role for 
leptin that may impact retinal inflammation. Accordingly, 
further investigation into the role of leptin in the retina, as 
well as the use of alternative obesity models, including a 
high-fat diet, are required to fully substantiate these results.
Lipid metabolites in ob/ob mice: It is known that changes 
in cellular metabolic pathways are associated with obesity 
[50,51]. In this study, we analyzed the metabolites of serum 
and retinal tissue in wild-type control and ob/ob mice, and 
found numerous metabolites were differentially expressed 
in the obese mice. PUFAs and branched-chain amino acids 
(BCAAs) showed an altered expression pattern in the ob/ob 
mouse serum and retinas. In humans, several neurodegenera-
tive diseases, including AMD, are linked to an increase in 
oxidative stress, which runs in parallel with lipid peroxidation 
of PUFAs [52]. The high lipid content of the photoreceptor 
outer segments, together with their high metabolic activity, 
makes photoreceptors highly susceptible to oxidative stress. It 
is possible that changes in the lipid composition of the retina 
may cause an increased level of oxidative damage, which may 
lead to the development of retinal degenerations.
The data suggest that leptin deficiency leads to an 
increased level of lipid metabolites, primarily PUFAs, in the 
serum and retinas of the ob/ob animals. These lipid metabo-
lites include lyso-phosphatidylcholine (lysoPC), diacyl phos-
phatidylcholine (PC aa), acyl-alkyl phosphatidylcholine (PC 
ae), hydroxy sphingomyelin (SM-OH), and sphingomyelin 
(SM). Of major interest are the lysoPC, which can stimulate 
macrophage activation and phagocytosis [53], and are asso-
ciated with neuroinflammation in diabetic retinopathy and 
AMD [54-56]. We have shown that ROS and RNS production 
is increased in ob/ob retinas. Taken together, the data suggest 
that changes in lipid metabolites in ob/ob mice may contribute 
to increased levels of oxidative stress in the retina.
In this study, we also observed an increase in BCAAs 
(leucine, isoleucine, and valine) in the ob/ob mouse serum or 
retinas. These findings may be due to a larger intake of food 
containing BCAAs in these hyperphagic mice; however, there 
is a strong correlation in the literature between increased 
BCAAs and obesity [57,58]. Due to the high incidence of 
insulin resistance associated with obesity, it remains unclear 
whether increased BCAAs are associated with obesity or 
insulin resistance [59]. Interestingly, increased BCAAs may 
have immunomodulatory effects on microglia, where cells 
cultured in high-BCAA-containing medium exhibit increased 
ROS production [60]. Additionally, these microglia produced 
decreased amounts of IGF-1, a neuroprotective and anti-
inflammatory factor, suggesting a potential link between 
BCAAs and neuroinflammation [60].
Leptin-deficient (ob/ob) mice on all backgrounds are 
known to exhibit hyperphagia, hyperlipidemia, insulin resis-
tance, reduced energy expenditure, and extreme obesity [61] 
and therefore, are considered a useful model for studying 
obesity and associated metabolic disturbances. It is known 
that the phenotype of ob/ob mice, including the levels of 
blood glucose and glycated hemoglobin (HbA1c), varies 
depending on the genetic background (reviewed in [61]). Ob/
ob mice are considered obese at 4 weeks of age compared 
to wild-type littermate controls, and on the C57BL/6J back-
ground can have mild to severe hyperglycemia and hyper-
insulinemia between 8 and 12 weeks of age [61]. However, 
mice on a C57BL/6J background do not develop severe type 
2 diabetes to the extent of mice on the C57BL/KsJ [61] or 
the BTBR [62,63] background. Leptin-deficient mice on the 
C57BL/6J background can have no change to mild increases 
in blood glucose levels, depending on the animals’ age with 
the maximum glucose concentrations observed at about 5 
months [21,22,64,65]. In addition, other studies have shown 
that ob/ob mice have statistically significantly increased 
blood glucose and HbA1c levels compared to wild-type or 
ob/+ mice on various genetic backgrounds, ages, and sexes 
[21,22,62,63,66]. In this set of experiments that used young 
adult animals (70-90 postnatal day), we did not observe any 
change in glucose or HbA1c levels in the colony of leptin-
deficient animals. This result indicates the susceptibility to 
retinal degeneration in young leptin-deficient animals may 
not be directly related to blood glucose levels but attributed 
to a combination of other metabolic dysfunctions leading to 
obesity.
Conclusion: The economic and social burdens of AMD and 
obesity are steadily increasing, with growing evidence of a 
causational relationship of AMD and obesity. In this study, 
we showed that increased oxidative stress and inflammation 
in the retina are linked to obesity in leptin-deficient (ob/ob) 
animals. We demonstrated that oxidative stress is increased 
in ob/ob retinas, associated with increases in the expression of 
complement components upstream of C3 and changes in lipid 
metabolites in the retina. The findings provide insight into 
how obesity predisposes the retina to complement activation 
and points to oxidative damage-mediated mechanisms that 
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may be addressed to some degree during aging with lifestyle 
approaches, including diet and exercise.
APPENDIX 1. VALIDATION OF PRIMARY 
ISOLATED MICROGLIA AS PURE CULTURES.
A: Representative plots of the gating strategy used in fluores-
cence-activated cell sorting (FACS) to isolate CD11b+ cells 
(red population) from whole retinas. B-F: Microglial cells 
were immunolabelled with monocyte markers IBA1 (B, red) 
and CD45 (C, red), with nuclei counterstained with DAPI. 
Immunolabelling for other common retinal cell markers 
including Rhodopsin (Rhod, D), GFAP (E) and a negative 
control (-ve, F) showed no positive labeling for these markers. 
G-H: Primary microglial cells were also screened for other 
common retinal cell markers including Rhod (G) and Gfap 
(H) using PCR. There was no expression in any of the isolated 
microglial cell samples for Rhod or Gfap, however positive 
PCR banding was detected in a whole retinal sample indi-
cating successful PCR amplification. Scale bars indicate 50 
µm. To access the data, click or select the words “Appendix 1”
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